Arena Pharmaceuticals Inc

Arena Pharmaceuticals Inc

ARNA

Get informed when a big investor buys or sells

+ Follow
Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Arena Pharmaceuticals IncArena Pharmaceuticals Inc-8.8--92%-0.1
$104.09

Current Fair Value

4.1% upside

Undervalued by 4.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$-509,258,000.00
Dividend Yield$- (-)
Earnings per Share$-11.33
Beta0.55
Outstanding Shares61,378,000

Return

Return on Equity-91.56%ROE
Return on Assets-78.56%
Return on Invested Capital-76.87%

Valuation & Multiples

P/E Ratio-8.82P/E Ratio
PEG-32.23PEG
Price to Sales-Price to Sales
Price to Book Ratio10.0Price to Book Ratio
Enterprise Value to Revenue-9430.7
Enterprise Value to EBIT0.92
Enterprise Value to Net Income0
Total Debt to Enterprise-0.08
Debt to Equity0.06Debt to Equity

Revenue Sources

No data

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Arena Pharmaceuticals Inc

CEO: Amit Munshi

Relevant Senate Committees

Finance

The most powerful economic committee, controlling taxation and entitlement spending (e.g., Medicare/Medicaid). It directly impacts pharmaceutical company profitability through tax policy and influences drug pricing and reimbursement through healthcare legislation.

Health, Education, Labor, and Pensions

Directly regulates the FDA, which is responsible for drug approvals, manufacturing standards, and post-market surveillance, making it the primary legislative body for the pharmaceutical sector. It also oversees NIH funding for medical research.

Judiciary

Oversees antitrust laws and intellectual property (patents), both of which are absolutely critical for the pharmaceutical industry regarding product exclusivity, competition, and mergers and acquisitions.